2019
Science (New York, N.Y.), (2019).364 6436 10.1126/science.aax6172.
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low- and middle-income countries.
2019
(2019).
2019
The Lancet. Infectious diseases, (2019).19 8 10.1016/S1473-3099(19)30282-8.
AD26.ZEBOV EBOLA BOOSTER VACCINATION INDUCES A STRONG ANAMNESTIC RESPONSE IN PREVIOUSLY VACCINATED PEOPLE AND PROVIDES RAPID PROTECTION AGAINST LETHAL EBOLA VIRUS CHALLENGE IN NHP.
2019
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2019).101,
2019
Nature, (2019).575 7781 10.1038/s41586-019-1656-7.
2019
Vaccine, (2019).37 20 10.1016/j.vaccine.2019.04.008.
2019
Medrxiv (2019). 10.1101/19004358.
2019
BMJ open, (2019).9 7 10.1136/bmjopen-2018-028228.
SAFETY AND IMMUNOGENICITY OF A 2-DOSE HETEROLOGOUS VACCINE AGAINST EBOLA IN AFRICAN CHILDREN AND ADOLESCENTS.
2019
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2019).101,
2019
The Journal of infectious diseases, (2019).221 7 10.1093/infdis/jiz581.